Speech delivered at the inauguration of the Vaccine Plant of the "Carlos J. Finlay" Institute, held at the Palace of Conventions, on the

Cuba Fidel Castro · President of Cuba

3 December 1993 · Inauguration of the Vaccine Plant of the "Carlos J. Finlay" Institute · Palace of Conventions, Cuba

Context
Castro spoke at the inauguration of the Vaccine Plant of the Carlos J. Finlay Institute at the Palace of Conventions, Havana, on December 3, 1993.
Main themes
Carlos J. Finlay's scientific legacy, vector transmission theory, vaccine development, Cuban biotechnology and pharmaceutical industry, yellow fever discovery, dengue epidemic response, Nobel Prize controversy, Latin American medicine, self-experimentation in science, mosquito-borne disease control
Duration
~36 min
88th percentile
Words
4,288
88th percentile
Sentences
161
83rd percentile
Readability
52
68th percentile
Grade
12.5
51st percentile
Syntax
3.25
78th percentile
Vocabulary
2.12
30th percentile

Translated from Spanish

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 54%53%
  • Ceremonial 30%29%
  • Economic 15%15%
  • Environmental 1%1%
  • Institutional 1%1%
  • Geopolitical 0%0%
  • Technological 0%0%
  • Not in focus 1%

161 sentences in 71 paragraphs

Distinguished personalities from the world of science and the pharmaceutical industry who are visiting us;

Guests;

Colleagues:

It always happens to me the same way. Perhaps I insist on not speaking because I am persistent; I do not know what value there is in the times I have asked María de los Angeles to give the closing speech and that I argue with the organizers of the events, but my only alternative is to come or not to come.

In reality, what can I say here where such valuable and capable colleagues have spoken? What can I say about Finlay that his biographer, Dr. López Sánchez, has not already said? We have the privilege of having a man like him, who has delved so deeply into Finlay's life, and who knows his work and life in such detail and depth.

He has already spoken about what his discovery meant for humanity. It could be said that sooner or later someone would have discovered it; that happens with everything; but who could calculate the number of lives he saved by developing that theory when he did, and by making its application possible when the circumstances arose in which that was possible? How many more years would humanity have taken to discover that transmitting agent?

The same theory served not only against yellow fever but also to discover the transmitters of other diseases. Can we forget malaria?

I could ask you, López Sánchez, if at that time it was already known that a mosquito was a transmitter of malaria (He replies that that was after Finlay). It was after Finlay, what year? (He replies that in 1902.) Had the influence of Aedes Aegypti already been discovered? (He explains that Ross's work was in 1902 and that Finlay had solved the problem of transmission by vectors in 1881.) In 1881, he had solved the problem in theory.

When did you say the first tests were done, in what year? (He says that the first time a disease was artificially reproduced was in 1881, and Finlay did it with his own family.)

And didn’t they give a prize to the brave one who let himself be bitten by the mosquito? You said here that he was saved; it was very interesting for all of us.

It must be said that among our scientists, I have known many people who have used the vaccine to test it on themselves. Those in the group that worked on the meningococcal vaccine used it on themselves and then tested it with family members, of course, after a fairly high level of safety, right? But at that time, it took a lot of courage for anyone to volunteer to test a theory on such a dangerous disease with no treatment.

While you were speaking, I was thinking that, from the moment the theory existed, the simple use of mosquito nets with cases of sick people was an important preventive element.

I was reminded not only of other diseases but also of dengue. We must see that the influence of that theory extends to dengue, which was later also found to be transmitted by the same type of mosquito.

We had a strong and really very severe epidemic of hemorrhagic dengue; we found ourselves engaged in a very serious struggle, and there were the theory and thought of Finlay present.

The battle was against the vector; efficient therapeutic methods were used, and it was very important to know what had to be done because we reached more than 300,000 cases of hemorrhagic dengue, and the treatment that was carried out reduced mortality to 159 cases. It is high, but I am convinced that in any other circumstance and in many countries of the world, an epidemic like that would have cost thousands of lives. That is to say, the therapy minimized mortality due to the meticulous care provided to the sick, but the fight against the vector was the key to eradicating the disease, and in the final phase, the hospitalization of all cases and avoiding contact with the mosquito. If the vector is known, the fight becomes more practical, more possible. Thus, until the day when not a single case of hemorrhagic dengue was reported, and since then our struggle has been to keep the vector at the lowest levels.

It is very sad to know that Finlay's merit has been so much debated. It is not our chauvinism, but it is total and absolutely proven the paternity of the discovery, the paternity of that theory.

I recently read that for many years there had been discussions about awarding the Nobel Prize to Finlay and that, after all, due to the opposition of certain interests, he was not awarded that prize, so even in that, Finlay was treated unjustly; and very recently a book was written in Europe disputing Finlay's merits, which is why we must continue to fight.

We believe in this with a very deep conviction; we recognize his merits, many in the world recognize them, they are recognized in Latin America, which is why we have used the date of his birth to commemorate Latin American Medicine Day.

I do not know if all Latin American countries commemorate it, but I know that there are some that commemorate Medicine Day on this date. Is this date universal? (López Sánchez explains that it is not commemorated everywhere.) In some countries it is commemorated (He clarifies that in some Latin American countries).

What is commemorated, Medicine Day or Latin American Medicine Day? (He says they talk about Medicine Day or Doctor's Day.) Is it based on the date of Finlay's birth or was this a coincidence? (He clarifies that it was later.) Is Finlay's life highly recognized in Latin America? (He says it is very much.) And has your book been widely published over there or have we lacked resources? You should have coordinated with a multinational advertising company to promote your book (He states that his book is in the hands of all doctors in Cuba).

But it is not in the hands of the rest of the doctors (He explains that it does not depend on him).

Whose responsibility is it, the publisher's, the paper's? (He clarifies that it is the publisher's.) Perhaps something more could have been done to disseminate your book over there and around the world; it is needed because there are still writings disputing Finlay's merits.

Rosa Elena told me that this morning you gave an excellent lecture defending the paternity of that theory (López Sánchez expresses that it was controversial). You say it was controversial. When I asked him: "And why don’t you use those arguments in the event we will have today?" He said: "Well, because we have foreign visitors, I don’t want to get into a controversial topic," which is as wise as Finlay's discovery. That’s how it is.

I also cannot speak about what the development of medicine in Cuba has meant since the triumph of the Revolution, because that was eloquently addressed by Comrade Teja; he gave us some figures that are striking and on which we can reflect.

He spoke to us, for example, that up to this moment, infant mortality is at 9.4%. We ourselves could not have expected that under the circumstances we are living in during the special period. We fought to maintain mortality at the level we had reached; we fought to try to prevent it from increasing; but the idea that it would drop below 10 was one of our objectives in normal times, considering that all these programs were carried out in normal times.

All those programs that Teja spoke about, which he enumerated, the list is long — I believe there were more than 50 measures associated with medicine that were developed in the last 10 or 12 years and that have been applied; this ranges from pediatric cardiovascular surgery to prenatal genetic programs, to cite a few cases, all these vaccination programs, the development of specialties, pediatric intensive therapy, perinatal intensive care — the set of these programs has made that decrease possible, and look at what the results of good work are, that even in such difficult circumstances, we can continue to advance and move forward.

Of course, this is also associated with the family doctor, one of the fifty-some programs or measures; but the family doctor is a whole program, the development of specialties is a whole program. So we could say that there are dozens of programs that have been applied in health matters to achieve these results; but when it was mentioned that there are 51,000 doctors, I confess that I was surprised, as if I had never heard the figure of the doctors we have, and it is something that is talked about very frequently. I myself talk about it very frequently, but time betrayed me; I did not realize that in August, 4,600 graduated, and with those, we reached 51,000 doctors.

The health successes that Teja spoke about must be associated, of course, with the presence of that human personnel and their capacity; but they could be better measured if we remember that at the triumph of the Revolution, there were 6,000 doctors, many of whom were unemployed, and 3,000 left; we were left with 3,000 doctors. Now for every one who left, there are 17, and we also have thousands of students in the faculties.

We have one medical school per province; that was another program; in the capital, there are several, so there are around 20 or 21 medical schools that we have. Of course, now we mainly use them for training nursing graduates, since we have already had to reduce the number of medical admissions in the faculties; but around 2,500 are being admitted per year. We have been reducing; at one point, more than double were being admitted, and so far, we have not had a surplus of doctors.

The problem with doctors is that there is no one to retire them. A division general, from the army, from whatever, can be retired; but a doctor cannot be retired, a doctor never retires (He looks at López Sánchez). Well, he is doing very well, right? (López Sánchez tells him that he has not retired.) You have not retired, and you have done very well not to retire, and be careful not to stop studying Finlay, because you would be failing in your most sacred duty. All these efforts have led to this situation.

When Teja spoke of hospitals and large hospital facilities, he spoke of the "Hermanos Ameijeiras" hospital. Initially, the "Hermanos Ameijeiras" hospital was going to be a bank — it was a central bank, I believe, that facility was not finished, then it burned down and was there for many years waiting for it to be done, or perhaps for money for the bank — but the point is that we transformed the project and converted the building, which already had many floors, into a hospital. Of course, many things had to be transformed, and I meditated when that hospital was mentioned: Well, did we do the right thing? What should be done first, a bank or a hospital?

The truth is that we made the hospital, and we still have not made the bank, and it is clear that banks are needed, right Benavides? (Referring to the head of the Mexican delegation, an important pharmaceutical industrialist.) Banks are needed because money is needed for all these projects.

In reality, we have a lot of money, but in Cuban pesos; in convertible currency, very little. However, we have managed to make do with the little we have to maintain these things during the entire special period.

I would say that the most extraordinary thing that the Minister of Health explained here is that we are maintaining these results at this time. That is truly admirable; we could call it miraculous to have achieved that.

I also cannot speak — although I am speaking — about what this new plant that is inaugurated today means; Conchita already did that. I can only say that I was in a contradiction because they tell me: On the 3rd, the Plant 3 is inaugurated, which is what that plant is called, of the "Finlay" Institute, with a capacity of 100 million vaccines annually. I say: And where are they going to inaugurate the plant? They explain to me: In the Palace of Conventions. And I said to myself: But how is that possible! I had never seen that. They said: It is impossible to inaugurate it here because of the green areas, because of what it would mean, because of the visitors we have so that they can be comfortable in a hall. I said: Well, that’s fine, it is impossible to inaugurate it here, but will it be possible to inaugurate it in a theater? It seems that yes, it is possible to inaugurate it in a theater; we are inaugurating it for now, what is needed is a little imagination, to use our imagination so that when we talk here about the plant, we are seeing it there, or imagining how the plant could be.

Thus, we also wanted to imagine how the Merieux plant in France was, whose founder is here; we have the honor of having him here with us.

When we were with the idea of making this plant and others, we wondered, how will Merieux's be? We saw some brochures, some advertising about that plant that undoubtedly looks very modern and makes a tremendous impression.

We had to turn to literature; we also had to turn to our experience because Plant 3 is the granddaughter of Plant 1. It was in Plant 1 where the practical problems of vaccine production were solved when it had already been developed and tested, but it was necessary to produce it industrially.

The ideas that were applied in that Plant 1 were very useful when it came to developing the concepts of how Plant 3 should be.

I believe there is a merit that is just to recognize our scientists, the "Finlay" group, Conchita, Gustavo, and the others, our designers, our project managers, and engineers, who were able to develop the idea of how Plant 3 should be, how the production flows should be, how the equipment should be.

Now one visits the completed plant and sees that it is a truly complex work, which requires, above all, a lot of quality, and it has been built with a lot of quality. Of course, there you can see the processes —I am not divulging any secrets—, the cultivation and fermentation area, the main areas, the purification area and the aseptic area —as Conchita calls it, I heard her say that word here—, that is, the finishing and packaging area of the products, which is the most complex. It is perfectly clear how it has been designed with great logic, with great rationality, in my opinion, as I am not an expert in that; perhaps Merieux, out of courtesy, will say that yes, that the plant is very well designed. I found the way everything is arranged to be very rational, and I have great confidence in the production capacity and in the quality of the production of that plant, since it is already the third one, even.

As Conchita mentioned here, this idea arises not with the commercial criteria that María de los Angeles spoke about, who frankly recognized that this plant also has economic purposes; our concern when we started working on the production of a vaccine against type B meningococcal meningitis was as a consequence of an epidemic we had. It was desperate to see every year more than a thousand cases with a high mortality rate, and a tremendous terror in families that their children, grandchildren, and little ones could be affected by the disease; because we must not only measure the direct damage caused by an epidemic or a disease in the people it affects and in the relatives of those people, but also the insecurity, the unrest that it sows in millions of people. It can be said that a vaccine like this, a vaccine against another disease, which is anguish, benefits millions of people. That is the value that these vaccines have, like all those that have been developed and those that are being developed.

We really have ambitious plans in this regard, and I believe that the figure Conchita provided justifies it: the 2.1 million children who still die for lack of vaccines that exist against diseases that are predictable or preventable —she said preventable, we should consult a good grammarian to tell us which word we should use—, and 8 million who suffer from diseases from which they die, for which there is still no prevention, although there may be treatment, of course.

The figure of 900 million children who get sick every year is impressive. I believe this gives an idea of the importance of work in the field of vaccines.

I remember, however, a well-known Irish writer —many of you may have read him, you may have heard of him, perhaps not so much the younger generation—, Bernard Shaw. Bernard Shaw was a sworn enemy of vaccines; I read him as a student, but I did not absorb the prejudices he had about vaccines; he said that it was a poison and a toxin that they injected into people, etc. I believe that objectively that theory is not sustainable, because vaccines have saved who knows how many billions of people.

The United Nations Population Fund gave me a watch that shows the projection of the population growth of Cuba and the world population, and I believe that yesterday it was at 5,541 million inhabitants —that varies, when a minute passes there are more inhabitants. That programmed device, which is small, is like a clock, provides all that data.

Now, without vaccines, those colossal reductions in infant mortality would not have been achieved. Of course, it is not only vaccines; there are therapeutic treatments, which have played a very important role; but vaccines have been decisive, because Third World countries generally do not have many therapeutic possibilities and have the possibilities of vaccines.

The colossal demographic growth we are experiencing, the increase of almost 100 million inhabitants per year, is quite associated with the development of vaccines. Now, any day, Conchita, they are going to partially blame you, and "Finlay" and other scientists of the world, for hunger on Earth, because the problems of how to preserve the life of the child have been solved, but the problems of how to feed him have not been solved, which is the great tragedy of our times. I do not want to delve into this, because I already said that I had nothing to talk about with everything that has already been said here.

I repeat that I would have nothing to say after María de los Angeles spoke about the historical issue, health strategies, and all those issues that gave rise to our program in this field. I believe she spoke explaining in political and historical terms, which is not prohibited, right?

I believe that history has spoken twice here, it spoke through the mouth of López Sánchez and through the mouth of María de los Angeles; he told the history of Finlay and she told the history of medicine in the Revolution. Teja spoke of the processes and Conchita of the vaccine and the plant; but I believe that everyone has also been remembered: Finlay, the doctors, because today is Doctor's Day, everyone has been warmly congratulated, to which I join wholeheartedly; the scientists were also congratulated and the workers who built this center were congratulated.

The center is inaugurated today, and they celebrate tomorrow Construction Workers' Day in the vicinity, on an avenue that runs alongside the facility.

The effort of many has been necessary; we cannot forget the designers, the engineers, the technical staff who worked on all this; those who worked on acquiring the equipment to ensure it was of the best quality, overcoming obstacles, as you can understand that there are to overcome in the midst of the blockade.

I consider that in this area we are doing well. I believe we have been accumulating a great potential in the field of vaccines, we are working on several vaccines; it has not been mentioned that we are even working or trying to contribute something to the vaccine against AIDS, one of the most fearsome plagues we are suffering, because it is a threat that grows, it is a danger that grows every day, to the extent that some data given about the situation in certain areas of the world are horrifying, and the fact that there are countries where 30% of the population is infected with the virus. Imagine a country with 30% of the population infected! The importance of both therapy and prevention of this disease, in which all the measures adopted so far have yielded modest results, does not stop the advance.

With very particular measures applicable in our country, since we started fighting against AIDS when there were very few cases, perhaps we are the country in the world where the AIDS epidemic has advanced the least, the country in the world where it has advanced the least. We have been acquiring important experience that is increasingly understood, but that is not applicable when the disease really becomes widespread.

Yes, López Sánchez, in this we have had to resort to some traditional methods —a certain form of quarantine— combined with special attention; it is not a total quarantine, far from it, it is a relative quarantine, a system that we are perfecting and, despite that, AIDS is still growing even in our country; despite that, it grows, but at least we have been able to keep it at reasonably low levels.

We are also working on that vaccine, we are working on vaccines against parasites, which is very important. I believe that this is one of the greatest challenges that medical science has.

We are also working on the meningococcal vaccine for Haemophilus, and we plan to combine the meningococcal B and the Haemophilus meningococcal in the same vaccine, it is one of the prospects that those at the "Finlay" Institute have; in that field we are making progress.

We are making progress in many other fields of health research, in biotechnology, in the pharmaceutical industry.

Another institute that we are going to finish was not mentioned here, which is the Institute of Ozone Research, which has proven to solve very important problems.

The Center for Molecular Immunology for the development and production of monoclonal antibodies is already advanced.

Perhaps the concept that in this development, science and production go hand in hand was not mentioned; attached to the research centers, factories are being built. We first build the research center and then the factory, which maintains a very constant and systematic relationship between research and production. It is an idea that we have tried and that we are applying in as many research centers as possible with good results.

We have dedicated efforts to this task, we have dedicated resources, and, like medicine, it has not been neglected in this special period we are living because, apart from the human benefits that they mean for our health and that many of these investigations can also mean for the rest of the world, they promise economic rewards for the country that we really need, which is why this branch will surely become, in the future, one of the most important economic branches of our homeland.

What can we say to you? Conchita thanked everyone. We thank the guests, especially the foreign guests; also the nationals, because some may have had to come, even, on bicycles or overcoming great difficulties in the transportation we have today.

We want to express our admiration for what Merieux did, of whom we hope to be partners and not competitors; coming to the inauguration of this plant is a reflection of his great passion for medicine and for vaccines, because he had a very committed program in his country and in Europe, and yet he sought 24 hours to travel to this side of the Atlantic, arrive here today after noon and return tomorrow at 6:00 in the morning.

We really have to thank and admire a gesture like that; we have to thank and admire the gesture of all those who traveled from important distances; I also mention the Argentines because they are as far away in flight hours as the French; the Mexicans are a little closer, but that does not stop us from greatly appreciating their presence here and the presence of..., say it (They say in the heart). Ah, closer in the heart too.

I will not say that the others are not close in the heart, because I would become very impolite and I would ruin all the work of María de los Angeles.

Everyone is close to the heart, really, although the Mexicans must be said to be historically very close, and without saying everything I am feeling.

We cannot forget the Brazilians, Colombians, and others.

I wish to thank you for sharing with us this Day of Medicine, this success of our researchers, this feat of our builders, and to tell you that we will always be willing to work and collaborate with you.

We will always keep you very much in mind, and we will always also remember this day and this meeting.

Thank you very much.